about
Formerly known as BeiGene and founded in 2010 in Beijing, BeOne is a commercial-stage biotech firm that produces oncology therapeutics. The company's main product is Brukinsa, which is a small-molecule drug that treats multiple forms of Non-Hodgkin l...
Read More
271.80
1.65
(0.61%)
205.2K
XNAS Volume
XNAS 22 Jun, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
BeiGene Ltd (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..